GLP-1 and GLP-2 as intestinal reparative therapies in inflammatory bowel disease: mechanisms, translation, and clinical opportunity

Inflammatory bowel disease remains a chronic condition in which a substantial proportion of patients fail to achieve durable clinical remission despite advances in therapy. Although the treatment landscape has expanded to include biologics and small-molecule agents, contemporary management is increa...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Joseph J. Lee, Pratikiran Bajgain, Amy L. Lightner
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Frontiers Media S.A. 2026-05-01
coleção:	Frontiers in Gastroenterology
Assuntos:	Crohn’s disease GLP GLP-1 GLP-2 receptor agonist IBD - inflammatory bowel disease ulcerative colitis
Acesso em linha:	https://www.frontiersin.org/articles/10.3389/fgstr.2026.1790420/full
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!